YEAR IN REVIEW
A Year in Review
B R I A N L E U T N E R , M B A , Administrative Director, Pardee Oncology Services
This year has been an interesting journey in cancer care due to the COVID-19 concerns across the country and our local region. The protocols for COVID-19 screening went into place early throughout Pardee and needed to be monitored on a more detailed level with our cancer patients. This pandemic also brought on virtual patient visits and virtual meetings between colleagues. The providers and staff had to learn new technologies and ways to communicate that still provided the highest quality of care, while keeping our patient satisfaction as a key priority. The oncology team stepped up to the challenge and remained open minded by creating new ways in approaching patient care to ensure that our patients, their families and co-workers remained safe while continuing to give the needed therapies and procedures to our patients. The Breast Center expanded its technologies to offer the community more access and increase our state of the art care for the region we serve. We added a second 3D mammography unit which allows more flexibility for patient scheduling due to the demand in our communities. The SmartCurve breast stabilization system was added to assist in decreasing the discomfort that our patients would often complain about when receiving their mammograms. Also, we are excited to now offer Automated Breast Ultrasound (ABUS) technology as a comfortable, non-ionizing alternative to other screening options for women with dense breasts. When used in addition to traditional mammography, the ABUS can improve breast cancer detection by 38 percent over mammography alone in those women with dense breast tissue. The medical oncology infusion volumes continued to increase with new immuno
3
2
3-D MAMMOGRAPHY SUITES A second suite was added to the Breast Center in 2019 (see page 7).
INDIVIDUALS SCREENED for prostate and skin cancer through Pardee’s free community screenings.
108 VIRTUAL CONFERENCING OF CARE TEAM
Allows patient’s multi-disciplinary team to continuously synchronize active plans for care and treatment.
CLINICAL TRIALS PATIENTS
enrolled since program’s inception.
1000+ PARTNERED WITH NFL AND AMERICAN CANCER SOCIETY
to receive NFL Change Grant funds for lung cancer screenings (see page 12).
